Percutaneous coronary intervention as an alternative to bypass surgery for unprotected LMCA stenosis

References

• Park SJ. Left Main Stem Disease. Informa Healthcare, Seoul, South Korea (2006).
   Google Scholar
• Park SJ, Kim YH, Lee BK et al. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation. J. Am. Coll. Cardiol.45(3), 351–356 (2005).
   PubMed Web of Science ®Google Scholar
• Chieffo A, Stankovic G, Bonizzoni E et al. Early and mid-term results of drug-eluting stent implantation in unprotected left main. Circulation111(6), 791–795 (2005).
   PubMed Web of Science ®Google Scholar
• Valgimigli M, van Mieghem CA, Ong AT et al. Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the rapamycin-eluting and taxus stent evaluated at Rotterdam Cardiology Hospital registries (RESEARCH and T-SEARCH). Circulation111(11), 1383–1389 (2005).
   PubMed Web of Science ®Google Scholar
• Price MJ, Cristea E, Sawhney N et al. Serial angiographic follow-up of sirolimus-eluting stents for unprotected left main coronary artery revascularization. J. Am. Coll. Cardiol.47(4), 871–877 (2006).
   PubMed Web of Science ®Google Scholar
• Palmerini T, Marzocchi A, Marrozzini C et al. Comparison between coronary angioplasty and coronary artery bypass surgery for the treatment of unprotected left main coronary artery stenosis (the Bologna Registry). Am. J. Cardiol.98(1), 54–59 (2006).
   PubMed Web of Science ®Google Scholar
• Lee MS, Kapoor N, Jamal F et al. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease. J. Am. Coll. Cardiol.47(4), 864–870 (2006).
   PubMed Web of Science ®Google Scholar
• Buszman PE, Kiesz SR, Bochenek A et al. Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization. J. Am. Coll. Cardiol.51(5), 538–545 (2008).
   PubMed Web of Science ®Google Scholar
• Kim YH, Dangas GD, Solinas E et al. Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis. Am. J. Cardiol.101(6), 801–806 (2008).
   PubMedGoogle Scholar
• Seung KB, Park DW, Kim YH et al. Stents versus coronary-artery bypass grafting for left main coronary artery disease. N. Engl. J. Med.358(17), 1781–1792 (2008).
   PubMed Web of Science ®Google Scholar
• de Lezo JS, Medina A, Pan M et al. Rapamycin-eluting stents for the treatment of unprotected left main coronary disease. Am. Heart J.148(3), 481–485 (2004).
   PubMed Web of Science ®Google Scholar
• Chieffo A, Morici N, Maisano F et al. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience. Circulation113(21), 2542–2547 (2006).
   PubMed Web of Science ®Google Scholar
• Iakovou I, Schmidt T, Bonizzoni E et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA293(17), 2126–2130 (2005).
   PubMed Web of Science ®Google Scholar
• Stone GW, Moses JW, Ellis SG et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N. Engl. J. Med.356(10), 998–1008 (2007).
   PubMed Web of Science ®Google Scholar
• Mauri L, Hsieh WH, Massaro JM, Ho KK, D’Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N. Engl. J. Med.356(10), 1020–1029 (2007).
   PubMed Web of Science ®Google Scholar
• Kuchulakanti PK, Chu WW, Torguson R et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation113(8), 1108–1113 (2006).
   PubMed Web of Science ®Google Scholar
• Farb A, Boam AB. Stent thrombosis redux – the FDA perspective. N. Engl. J. Med.356(10), 984–987 (2007).
   PubMed Web of Science ®Google Scholar
• Marroquin OC, Selzer F, Mulukutla SR et al. A comparison of bare-metal and drug-eluting stents for off-label indications. N. Engl. J. Med.358(4), 342–352 (2008).
   PubMedGoogle Scholar
• Tu JV, Bowen J, Chiu M et al. Effectiveness and safety of drug-eluting stents in Ontario. N. Engl. J. Med.357(14), 1393–1402 (2007).
   PubMed Web of Science ®Google Scholar
• Walters DL, Harding SA, Walsh CR, Wong P, Pomerantsev E, Jang IK. Acute coronary syndrome is a common clinical presentation of in-stent restenosis. Am. J. Cardiol.89(5), 491–494 (2002).
   PubMedGoogle Scholar
• Nayak AK, Kawamura A, Nesto RW et al. Myocardial infarction as a presentation of clinical in-stent restenosis. Circ. J.70(8), 1026–1029 (2006).
   PubMedGoogle Scholar
• Takagi T, Stankovic G, Finci L et al. Results and long-term predictors of adverse clinical events after elective percutaneous interventions on unprotected left main coronary artery. Circulation106(6), 698–702 (2002).
   PubMed Web of Science ®Google Scholar
• Biondi-Zoccai GGL, Lotrionte M, Moretti C et al. A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease. Am. Heart J.155(2), 274–283 (2008).
   PubMed Web of Science ®Google Scholar
• Tan WA, Tamai H, Park SJ et al. Long-term clinical outcomes after unprotected left main trunk percutaneous revascularization in 279 patients. Circulation104(14), 1609–1614 (2001).
   PubMed Web of Science ®Google Scholar
• Valgimigli M, Malagutti P, Rodriguez-Granillo GA et al. Distal left main coronary disease is a major predictor of outcome in patients undergoing percutaneous intervention in the drug-eluting stent era: an integrated clinical and angiographic analysis based on the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registries. J. Am. Coll. Cardiol.47(8), 1530–1537 (2006).
   PubMed Web of Science ®Google Scholar
• Kim YH, Ahn JM, Park DW et al. EuroSCORE as a predictor of death and myocardial infarction after unprotected left main coronary stenting. Am. J. Cardiol.98(12), 1567–1570 (2006).
   PubMed Web of Science ®Google Scholar
• Baierl V, Baumgartner S, Pollinger B et al. Three-year clinical follow-up after strontium-90/yttrium-90 β-irradiation for the treatment of in-stent coronary restenosis. Am. J. Cardiol.96(10), 1399–1403 (2005).
   PubMed Web of Science ®Google Scholar
• Chieffo A, Park SJ, Valgimigli M et al. Favorable long-term outcome after drug-eluting stent implantation in nonbifurcation lesions that involve unprotected left main coronary artery. A multicenter registry. Circulation116(2), 158–162 (2007).
   PubMed Web of Science ®Google Scholar
• Valgimigli M, Malagutti P, Rodriguez Granillo GA et al. Single-vessel versus bifurcation stenting for the treatment of distal left main coronary artery disease in the drug-eluting stenting era. Clinical and angiographic insights into the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated At Rotterdam Cardiology Hospital (T-SEARCH) registries. Am. Heart J.152(5), 896–902 (2006).
   PubMedGoogle Scholar
• Kim YH, Park SW, Hong MK et al. Comparison of simple and complex stenting techniques in the treatment of unprotected left main coronary artery bifurcation stenosis. Am. J. Cardiol.97(11), 1597–1601 (2006).
   PubMed Web of Science ®Google Scholar
• Park SJ, Park SW, Hong MK et al. Stenting of unprotected left main coronary artery stenoses: immediate and late outcomes. J. Am. Coll. Cardiol.31(1), 37–42 (1998).
   PubMed Web of Science ®Google Scholar
• Costa MA, Gigliotti OS, Zenni MM, Gilmore PS, Bass TA. Synergistic use of sirolimus-eluting stents and intravascular ultrasound for the treatment of unprotected left main and vein graft disease. Catheter Cardiovasc. Interv.61(3), 368–375 (2004).
   PubMedGoogle Scholar
• Das P, Meredith I. Role of intravascular ultrasound in unprotected left main percutaneous coronary intervention. Expert Rev. Cardiovasc. Ther.5(1), 81–89 (2007).
   PubMedGoogle Scholar
• Agostoni P, Valgimigli M, Van Mieghem CAG et al. Comparison of early outcome of percutaneous coronary intervention for unprotected left main coronary artery disease in the drug-eluting stent era with versus without intravascular ultrasonic guidance. Am. J. Cardiol.95(5), 644–647 (2005).
   PubMedGoogle Scholar
• Mintz GS, Weissman NJ. intravascular ultrasound in the drug-eluting stent era. J. Am. Coll. Cardiol.48(3), 421–429 (2006).
   PubMed Web of Science ®Google Scholar
• Smith SC Jr, Feldman TE, Hirshfeld JW Jr et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (ACC/AHA/SCAI Writing Committee to update 2001 guidelines for percutaneous coronary intervention). Circulation113(7), e166–e286 (2006).
   PubMedGoogle Scholar
• Takaro T, Hultgren HN, Lipton MJ, Detre KM. The VA cooperative randomized study of surgery for coronary arterial occlusive disease II. Subgroup with significant left main lesions. Circulation54(6 Suppl.), III107–III117 (1976).
   PubMedGoogle Scholar
• Chaitman BR, Fisher LD, Bourassa MG et al. Effect of coronary bypass surgery on survival patterns in subsets of patients with left main coronary artery disease. Report of the Collaborative Study in Coronary Artery Surgery (CASS). Am. J. Cardiol.48(4), 765–777 (1981).
   PubMed Web of Science ®Google Scholar
• Ong ATL, Serruys PW, Mohr FW et al. The Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) study: design, rationale, and run-in phase. Am. Heart J.151(6), 1194–1204 (2006).
   PubMed Web of Science ®Google Scholar